InvestorsHub Logo
Followers 18
Posts 1365
Boards Moderated 0
Alias Born 12/30/2013

Re: ORrep8 post# 19466

Saturday, 01/03/2015 10:56:41 AM

Saturday, January 03, 2015 10:56:41 AM

Post# of 140478
Just a shock it took them so long to make that decision to go for broad surgical indications from the get go. It was quite clear they should have gone that route from the beginning like TRXC. I guess they were considering all of the human trials they will have to do for each individual indication. Costly, but worth it in the end